Dr Chris Lamb has been awarded a Rising Star award by the United European Gastroenterology (UEG), a non-profit organisation for excellence in digestive health in Europe.
The UEG awards the Rising Star prize every year to the most promising, emerging scientists based of a track record of international quality research and developing scientific independence.
Chris is an honorary gastroenterologist at Newcastle Hospitals and principal investigator at the Translational and Clinical Research Institute at Newcastle University,
On winning the Rising Star award, Chris says:
“I’m proud of being able to work with patients, clinicians and scientists and love the unique job that I have. In my research role I work to understand the biomedical mechanisms behind treatments for inflammatory bowel disease. I hope that my research will help patients to receive the best treatments for them at the right time in the course of their Crohn’s disease or ulcerative colitis.”
“I wish to inspire others that academia is accessible at all career stages by demonstrating that a diverse research portfolio, grounded in patient experience and recognition of the unmet medical need, can lead to patient benefit. I wish to act as a role model by describing my experience of clinical and laboratory research so others realise “I can do that!”
Chris is currently chief investigator for IBD-RESPONSE, a UK-wide study which aims to provide a better understanding of the relationship between the gut microbiome and treatment outcomes in inflammatory bowel disease.
Chris is also the National Institute for Health Research (NIHR) Biomedical Research Centre emerging lead for liver disease, multi-morbidity and liver research.
His previous accolades include winning the British Society of Gastroenterology young gastroenterologist of the year (emerging leader). Chris continues to works closely with Crohn’s and Colitis UK to support young people with bowel disease.
